IC50: ≤10 μM (myosin II)[1]
JB002 is a myosin II inhibitor, with an IC50 of ≤10 μM. JB002 can be used for the research of muscle spasticity, chronic musculoskeletal pain, and pertrophic cardiomyopat[1].
JB002 在心脏和骨骼肌球蛋白之间表现出良好的选择性,但对非肌肉 IIB 没有可检测的活性[1]。
[1]. Smith JD, et, al. Isoform selectivities of novel 4-droxycoumarin imines as inhibitors of myosin II. Eur J Med Chem. 2022 Dec 12;247:115008.
















